Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

06 November 2017: Short Communications  

Is Kidney Donor Profile Index (KDPI) Valid for Hepatitis C Aviremic Kidneys?

Lena Sibulesky A 1*, Catherine E. Kling E 1, Ajit P. Limaye E 2, Christopher K. Johnson E 3

DOI: 10.12659/AOT.905428

Ann Transplant 2017; 22:663-664

0 Comments

Abstract

ABSTRACT: The Kidney Donor Risk Index (KDRI) and Kidney Donor Profile Index (KDPI) assist clinicians with the selection of deceased donor kidneys. This scoring system is based on 10 donor factors including Hepatitis C virus (HCV) status from serological or NAT testing. The donor HCV status (i.e., having either a positive hepatitis C antibody (Ab) or nucleic acid testing (NAT) result) increases the hazard ratio for graft failure by 1.27 and the KDPI by approximately 20%. Whether this increase in KDPI is a true reflection of graft quality for HCV seropositive but not viremic donors is unknown. Further investigations are needed to maximize the use of these organs.

Keywords: Hepatitis C Antibodies, Tissue and Organ Procurement, Tissue Donors

References

1. Israni AK, Salkowski N, Gustafson S, New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes: J Am Soc Nephrol, 2014; 25(8); 1842-48, pmid: 24833128

2. Rao PS, Schaubel DE, Guidinger MK, A comprehensive risk quantification score for deceased donor kidneys: The kidney donor risk index: Transplantation, 2009; 88(2); 231-36, pmid: 19623019

3. Abbott KC, Bucci JR, Matsumoto CS, Hepatitis C and renal transplantation in the era of modern immunosuppression: J Am Soc Nephrol, 2003; 14(11); 2908-18, pmid: 14569101

4. , UNet System Notice – Upcoming Waitlist and and DonorNet changes will reflect policy changes regarding infectious diseases screening [Internet]: UNOS System Notices - General Notice, 2017 [cited 16 March 2017]. Available from:https://portal.unos.org/ViewSystemNotice.aspx?id=3074

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358